UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Type I Interferons in Autoimmune Disease

Annual review of pathology, 2019-01, Vol.14 (1), p.369-393

2019

Volltextzugriff (PDF)

Anti-interferon alpha treatment in SLE

Clinical immunology (Orlando, Fla.), 2013-09, Vol.148 (3), p.303-312

2013

Volltextzugriff (PDF)

Targeting of type I interferon in systemic autoimmune diseases

Translational research : the journal of laboratory and clinical medicine, 2015-02, Vol.165 (2), p.296-305

2015

Volltextzugriff (PDF)

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

Annals of the rheumatic diseases, 2022-03, Vol.81 (3), p.303-305

2022

Volltextzugriff (PDF)

What Causes Lupus Flares?

Current rheumatology reports, 2016-03, Vol.18 (3), p.14, Article 14

2016

Volltextzugriff (PDF)

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Science translational medicine, 2018-01, Vol.10 (423)

2018

Volltextzugriff (PDF)

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Lupus, 2024-08, Vol.33 (9), p.938-947

2024

Volltextzugriff (PDF)

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Frontiers in immunology, 2022-08, Vol.13, p.980079

2022

Volltextzugriff (PDF)

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2686-2696

2016

Volltextzugriff (PDF)

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Rheumatology (Oxford, England), 2023-07, Vol.62 (7), p.2534-2538

2023

Volltextzugriff (PDF)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.121-131

2021

Volltextzugriff (PDF)

Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.740-747

2017

Volltextzugriff (PDF)

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Arthritis care & research (2010), 2022-04, Vol.74 (4), p.656-664

2022

Volltextzugriff (PDF)

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

The Journal of experimental medicine, 2022-11, Vol.219 (11)

2022

Volltextzugriff (PDF)

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1003-1009

2011

Volltextzugriff (PDF)

Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps

Arthritis & rheumatology (Hoboken, N.J.), 2012-04, Vol.64 (4), p.982-992

2012

Volltextzugriff (PDF)

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1905-1913

2011

Volltextzugriff (PDF)

Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus

Clinical immunology (Orlando, Fla.), 2016-11, Vol.172, p.34-43

2016

Volltextzugriff (PDF)

Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo

The Journal of immunology (1950), 2009-01, Vol.182 (1), p.34-38

2009

Volltextzugriff (PDF)

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Journal of rheumatology, 2017-07, Vol.44 (7), p.1024-1031

2017

Volltextzugriff (PDF)

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Arthritis & rheumatology (Hoboken, N.J.), 2010-12, Vol.62 (12), p.3607-3614

2010

Volltextzugriff (PDF)

A case of inflammatory cerebral amyloid angiopathy after ischemic stroke - a potential risk factor related to blood-brain barrier disruption

Clinical imaging, 2022-02, Vol.82, p.161-165

2022

Volltextzugriff (PDF)

Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients

The Journal of immunology (1950), 2011-08, Vol.187 (3), p.1298-1303

2011

Volltextzugriff (PDF)

Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2013-06, Vol.65 (6), p.1592-1602

2013

Volltextzugriff (PDF)

Microarray Analysis of Interferon-regulated Genes in SLE

Autoimmunity (Chur, Switzerland), 2003-12, Vol.36 (8), p.481-490

2003

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(54)
Buchkapitel
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Rheumatology
(33)
Female
(23)
Lupus Erythematosus, Systemic - Immunology
(19)
Adult
(17)
Male
(16)
Systemic Lupus Erythematosus
(16)
Biological And Medical Sciences
(14)
Immunology
(14)
Lupus Erythematosus, Systemic - Genetics
(14)
Middle Aged
(13)
Aged
(12)
Lupus Erythematosus, Systemic - Blood
(12)
Medical Sciences
(12)
Animals
(9)
Lupus
(9)
Lupus Erythematosus, Systemic - Drug Therapy
(8)
Treatment Outcome
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Type I Interferons in Autoimmune Disease

Anti-interferon alpha treatment in SLE

Targeting of type I interferon in systemic autoimmune diseases

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

What Causes Lupus Flares?

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus

Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

A case of inflammatory cerebral amyloid angiopathy after ischemic stroke - a potential risk factor related to blood-brain barrier disruption

Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients

Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus

Microarray Analysis of Interferon-regulated Genes in SLE

Aktive Filter

Suchergebnisse filtern